Study to Investigate the Clinical Benefits of Dietary Supplement Quercetin for Managing Early COVID-19 Symptoms at Home

• Status: Completed
• Trial end date: 2021-08-29
• Target enrollment: 0
• Participant gender: All

Summary

Quercetin is a flavonoid dietary supplement that occurs in many edible fruits and vegetables. It has remarkable antioxidant, anti-inflammatory, immunoprotective and antiviral properties. It is widely used to boost the body immune system against infections and keeping healthy life-style. The purpose of the present study is to investigate the potential benefits of quercetin for preventing COVID-19 disease progression and symptoms improvement in the early stage of infection.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: King Edward Medical University
• Treatments: Quercetin

Criteria

Inclusion Criteria:

• Patients must be 18 years of age or older, of either gender

• Patients must be tested positive for SARS-CoV-2 by RT-PCR

• Patients must exhibit typical symptoms of COVID-19 disease at screening such as fever, fatigue, a dry and contagious cough, loss of appetite, body aches, shortness of breath, mucus or phlegm, sore throat, headache, chills, sometimes with shaking, loss of smell or taste, congestion or runny nose, nausea, or vomiting, diarrhea, muscular pain etc.

• Patients must be in the early stage of COVID-19 disease who do not require hospitalisation at the time of screening

• Patients must be under the care of a Physician for diagnosis of COVID-19

• Patients who have signed informed consent

Exclusion Criteria:

• Patients with proven hypersensitivity or allergic reaction to quercetin

• Patients with known chronic kidney disease with estimated creatinine clearance < 50 mL/minute or need for dialysis

• Patients who are severely hypotensive defined as needing hemodynamic pressors to maintain blood pressure

• Patients with moderate or severe thrombocytopenia (platelet count <100 × 10⁹/L);

• Pregnant patients

• Patients declining to participate